Developing in-licensed protein inhibitors for solid tumors and blood cancers.
Industry: Health Care
First Day Return: -2.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/20/2015 |
Offer Price | $8.00 |
Price Range $8.00 - $8.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/04/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | La Jolla, CA, United States |
Founded | 2014 |
Employees at IPO | 21 |
Website www.kuraoncology.com |